Results 231 to 240 of about 34,349 (240)

Amendment to nonexclusive patent and know-how license to use the phage display technology to exploit, make, have made, use, sell, import and sublicense diagnostic products containing one or more antibodies as binding moiety and processes, including devices, compounds, kits, in vitro diagnostic and research reagents, services, and other products that are not already covered diagnostic or therapeutic products, for all indications, excluding research products.

2012
openaire   +1 more source

Nonexclusive patent and process license to use, offer, sell, make, have made and import reagents and kits and to practice diagnostic services for stool-based detection of any disease or condition including pre-cancers, for research and development, clinical testing services, FDA approved kits, and screening assays for colorectal cancer, with use of DNA sequences related to the APC and the p53 genes.

2009
openaire   +1 more source

Semi-exclusive patent and know-how license to make, have made, use, offer, sell, import and sublicense diagnostic products, reagents or kits for carrying out an extracorporeal diagnostic assay to determine BNP levels in biological materials using a hand-held or other point-of-care testing device and reader, including screening for cardiovascular problems such as congestive heart failure.

2006
openaire   +1 more source

Co-exclusive patent and technology license to develop, make, have made, use, sell, import and sublicense products related to RNA interference mediating small RNA molecules as research reagents, including in a kit format, for research or educational purposes, internal and collaborative research uses, therapeutic and prophylactic uses, diagnostic uses for purposes of therapeutic monitoring, but excluding all other diagnostic uses, for human and veterinary diseases.

2011
openaire   +1 more source

Nonexclusive patent and process license to make, have made, use, offer, sell, practice and import diagnostic services, reagents and kits to determine the presence, absence or variations of a nucleic acid in stool samples, for screening, diagnosis, prognosis and monitoring to detect changes associated with colorectal cancer, and excluding instruments and software for performing assays.

2007
openaire   +1 more source

Exclusive patent and process license to develop, make, have made, use, sell, offer, lease, import and sublicense veterinary products, including diagnostic products for determination of intervention for prevention and/or treatment of disease, including reagents and kits, and therapeutic and prophylactic products including vaccines, for all fields, and to provide services using all licensed products or process.

2014
openaire   +1 more source

Exclusive and nonexclusive patent and proprietary information license to make, have made, use, offer, sell, provide and sublicense diagnostic services and products such as kits, instruments, tools, reagents and material for the clinical analysis of the BRCA2 gene or protein, and research products for detection purposes related to the BRCA2 gene, associated with inherited susceptibility to breast cancer.

1998
openaire   +1 more source